New study demonstrates MaiLi dermal filler safety
Aesthetic manufacturer Sinclair has released a new study demonstrating the safety ofdermal filler MaiLi. The company explains that the research is based on an observation period from February 2021 to
Aesthetic manufacturer Sinclair has released a new study demonstrating the safety ofdermal filler MaiLi. The company explains that the research is based on an observation period from February 2021 to
Pharmaceutical company Sinclair held a Power Brunch in London to investigate the topic of women’s experiences with judgements on appearance.
Pharmaceutical company Sinclair has unveiled a new global campaign with creative marketing agency Smyle.
Pharmaceutical company Sinclair has launched a competition to highlight the range of applications and outcomes that can be achieved using the MaiLi filler for the lips.
Pharmaceutical company Sinclair has begun a new global brand transformation.
Pharmaceutical company Sinclair has launched a new campaign on its hyaluronic acid fillers for the eyes and lips.
On April 4 pharmaceutical company Sinclair Pharma hosted the MaiLi Experience, as an educational event for its new HA filler.
Pharmaceutical company Sinclair Pharma has introduced The MaiLi Experience to provide a touchpoint for clinicians to learn how to treat with MaiLi.
The International College of Aesthetic Nurses (ICAN) held its second virtual conference in January.
Pharmaceutical company Sinclair Pharma is launching a new hyaluronic acid (HA) facial filler called MaiLi.